Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Journal of Fungi (Basel, Switzerland)|June 2, 2021
Penetration of Isavuconazole in Ascites Fluid of Critically Ill PatientsTobias Lahmer, Gonzalo Batres Baires, Roland M Schmid, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecidCornelia B Landersdorfer, Carl M J Kirkpatrick, Martina Kinzig, et al.
Antimicrobial Agents and Chemotherapy|December 11, 2013
Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltrationRachel F Eyler, A Mary Vilay, Ahmed M Nader, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2022
Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent HemodialysisTilman Lingscheid, Martina Kinzig, Anne Krüger, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 5, 2018
First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteersYuanyuan Jiao, Tae Hwan Kim, Xun Tao, et al.
Pharmaceutics|June 21, 2019
Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein BindingNirav R Shah, Jürgen B Bulitta, Martina Kinzig, et al.
Journal of Clinical Pharmacology|May 20, 2020
A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A InhibitionXia Li, Lisa Junge, Max Taubert, et al.
Mycoses|May 10, 2022
Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysisRainer Höhl, Ralph Bertram, Martina Kinzig, et al.
Mycoses|September 13, 2023
Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID-19Ralph Bertram, Hans-Theodor Naumann, Vanessa Bartsch, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plagueHenry S Heine, Arnold Louie, Jeffrey J Adamovicz, et al.
Pageof 9